Bessudo Alberto - Department of Medical Oncology and Hematology, California Cancer Associates for Research and Excellence

基本信息

浏览量：126

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 89 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

Safety and Efficacy of Vicriviroc (MK-7690) in Combination with Pembrolizumab in Patients with Advanced or Metastatic Microsatellite Stable Colorectal Cancer

Alberto Bessudo, Abdul Mustajeeb Haseeb,James A. Reeves,Xiaofu Zhu,Lucas Wong, Vincent Giranda,Leah Suttner,Fang Liu,Manash Chatterjee,Sunil Sharma

CLINICAL COLORECTAL CANCERno. 3 (2024): 285-294

引用0浏览0WOS引用

BETA Prime: a First-in-man Phase 1 Study of AdAPT-001, an Armed Oncolytic Adenovirus for Solid Tumors

Anthony P. Conley,Christina L. Roland,Alberto Bessudo,Brian R. Gastman,Victoria M. Villaflor,Christopher Larson,Tony R. Reid,Scott Caroen,Bryan Oronsky,Meaghan Stirn,Jeannie Williams,Erica Burbano,Angelique Coyle,Minal A. Barve,Naveed Wagle,Nacer Abrouk,Santosh Kesari

CANCER GENE THERAPYno. 4 (2024): 517-526

引用0浏览0WOSNATURE引用

1455 Phase 1 Study of XTX101, a Tumor-Activated, Fc-enhanced Anti-Ctla-4 Monoclonal Antibody, in Combination with Atezolizumab in Patients with Advanced Solid Tumors

Diwakar Davar, Ryan J Sullivan, John Knecht, Andrae L Vandross, Cesar A Perez,Alberto Bessudo,Ekta Patel,Damiano Fantini, Meghan Duncan, David Crowe, Sattanathan Paramasivan, Anurag Gupta,Katarina Luptakova, Aparna R Parikh

Late-Breaking Abstracts (2024)

引用0浏览0引用

COVALENT-102: A Phase 1/1b Study of BMF-219, A Menin Inhibitor in Patients with Unresectable, Metastatic NSCLC, PDAC, and CRC

S. Patel,D. Hong, S. A. Cohen,C. Fountzilas,D. Sommerhalder, S. Radhi, A. Benson,K. He,E. Pisick,A. Bessudo, H. Duvivier,T. Tong, B. Munneke, Y. Kosaka, U. Ahmed,A. Cacovean, S. Morris,T. Butler, A. Spira

JOURNAL OF THORACIC ONCOLOGYno. 11 (2023): S363-S363

引用0浏览0引用

Phase 1/2 Study of XTX101, a Masked, Tumor-Selective Fc-modified Anti-Ctla4, in Patients with Advanced Solid Tumors

Diwakar Davar, John George Knecht,Andrae Lavon Vandross,Cesar Augusto Perez,David Michael Miller,John D. Powderly,Alberto Bessudo,Ekta Patel,Damiano Fantini,Sattanathan Paramasivan,David Crowe,Meghan Duncan, Susan Uptain,Katarina Luptakova,Ryan J. Sullivan

JOURNAL OF CLINICAL ONCOLOGYno. 16 (2023)

引用0浏览0引用

P2.12-03 COVALENT-102: A Phase 1/1b Study of BMF-219, A Menin Inhibitor in Patients with Unresectable, Metastatic NSCLC, PDAC, and CRC

S. Patel,D. Hong, S.A. Cohen,C. Fountzilas,D. Sommerhalder, S. Radhi, A. Benson,K. He,E. Pisick,A. Bessudo, H. Duvivier,T. Tong, B. Munneke, Y. Kosaka, U. Ahmed,A. Cacovean, S. Morris,T. Butler, A. Spira

Journal of Thoracic Oncologyno. 11 (2023): S363-S363

引用0浏览0引用

Abstract LB_A17: Trial in Progress: First-in-human Phase I Dose-Escalation Study of a Novel Bicycle Toxin Conjugate (BT5528) Targeting EphA2 in Patients with Advanced Solid Tumors

Elisa Fontana,Babar Bashir,Judy S. Wang,Raid Aljumaily,Jean-Pascal Machiels, Maria Vieito,Gerald Falchook,Louise Carter, Bernard Doger de Spéville,Alastair Greystoke,Sang Wun Kim,Nuria Kotecki,Alexander I. Spira,Irene Moreno Candilejo,Bristi Basu,Hans Prenen,Alberto Bessudo,Misako Nagasaka, Jordi Rodón Ahnert,Joo-Hwan Park, Min-Yuen Teo,Julia Rotow,Jie Liu,Assunta De Rienzo,Mengyao Li, Adriana Domingo, Hanna Orr,Gavin Bennett, Rajiv Sharma,Meredith McKean

Molecular Cancer Therapeuticsno. 12_Supplement (2023)

引用0浏览0引用

1817P A Phase I/II Efficacy and Safety Study of LAE001/prednisone and Afuresertib in Patients with Metastatic Castration-Resistant Prostate Cancer (mcrpc) Following 1-3 Lines of Standard of Care

E. Diamond,C. Kwak, D. Orr, A. Bamidele,I.G. Jeong,A. Bessudo,C. Dunshee, S. Henderson,J.Y. Joung, S. Lee,J. Chaves, D. Slater,A. Patnaik,C. Pieczonka, W. Lee,Y.D. Choi, P. Guo, K. Ma, E. Cao, Y. Yue

Annals of Oncology (2023): S985

引用0浏览0引用

A Phase 1/2 Study of Ixazomib in Place of Bortezomib or Carfilzomib in a Subsequent Line of Therapy for Patients with Multiple Myeloma Refractory to Their Last Bortezomib or Carfilzomib Combination Regimen

David Daniely,Eli Forouzan,Tanya M. Spektor,Alexa Cohen,Jacob D. Bitran,Gigi Chen,Mehdi M. Moezi,Alberto Bessudo, John Hrom,Shahrooz Eshaghian,Regina A. Swift,Benjamin M. Eades,Clara Kim,Stephen Lim,James R. Berenson

Experimental Hematology（2022）

引用2浏览0WOS引用

BETA PRIME: Phase I study of AdAPT-001 as monotherapy and combined with a checkpoint inhibitor in superficially accessible, treatment-refractory solid tumors

Santosh Kesari,Alberto Bessudo,Brian R. Gastman,Anthony P. Conley,Victoria M. Villaflor,Lisle M. Nabell, DeLisa Madere,Emma Chacon, Christina Spencer,Li Li,Christopher Larson,Tony Reid,Scott Caroen,Bryan Oronsky,Meaghan Stirn,Jeannie Williams,Minal A. Barve

FUTURE ONCOLOGY（2022）

引用4浏览0WOS引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn